Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Whiting

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
British Journal of Pharmacology|February 1, 1995
The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitroE H Wong, R Clark, E Leung, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenololD R Blue, R A Bond, N Adham, et al.
Journal of Medicinal Chemistry|June 1, 1982
Structure-activity relationships for 2-substituted imidazoles as alpha 2-adrenoceptor antagonistsJ M Caroon, R D Clark, A F Kluge, et al.
Journal of Medicinal Chemistry|November 1, 1981
Synthesis and antihypertensive activity of a series of 8-substituted 1-oxa-3,8-diazaspiro[4.5]decan-2-onesJ M Caroon, R D Clark, A F Kluge, et al.
Journal of Medicinal Chemistry|June 1, 1983
Antihypertensive 9-substituted 1-oxa-4,9-diazaspiro[5.5]undecan-3-onesR D Clark, J M Caroon, D B Repke, et al.
Neuroreport|December 20, 1996
The 5-HT3 receptor antagonist, RS-56812, enhances delayed matching performance in monkeysA V Terry, J J Buccafusco, M A Prendergast, et al.
Neuropharmacology|March 1, 1994
(R) and (S) RS 56532: mixed 5-HT3 and 5-HT4 receptor ligands with opposing enantiomeric selectivityR M Eglen, D W Bonhaus, R D Clark, et al.
European Journal of Pharmacology|March 30, 1993
The effect of the 5-HT3 receptor antagonist, RS-42358-197, in animal models of anxietyB Costall, A M Domeney, M E Kelly, et al.
General Pharmacology|July 1, 1995
Chronic manipulation of dietary salt modulates renal physiology and kidney dopamine receptor subtypes: functional and autoradiographic studiesN A Sharif, J L Nunes, K D Lake, et al.
British Journal of Pharmacology|August 1, 1997
Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylaseW C Stanley, B Li, D W Bonhaus, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
British Journal of Pharmacology|February 1, 1995
The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitroE H Wong, R Clark, E Leung, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenololD R Blue, R A Bond, N Adham, et al.
Journal of Medicinal Chemistry|June 1, 1982
Structure-activity relationships for 2-substituted imidazoles as alpha 2-adrenoceptor antagonistsJ M Caroon, R D Clark, A F Kluge, et al.
Journal of Medicinal Chemistry|November 1, 1981
Synthesis and antihypertensive activity of a series of 8-substituted 1-oxa-3,8-diazaspiro[4.5]decan-2-onesJ M Caroon, R D Clark, A F Kluge, et al.
Journal of Medicinal Chemistry|June 1, 1983
Antihypertensive 9-substituted 1-oxa-4,9-diazaspiro[5.5]undecan-3-onesR D Clark, J M Caroon, D B Repke, et al.
Neuroreport|December 20, 1996
The 5-HT3 receptor antagonist, RS-56812, enhances delayed matching performance in monkeysA V Terry, J J Buccafusco, M A Prendergast, et al.
Neuropharmacology|March 1, 1994
(R) and (S) RS 56532: mixed 5-HT3 and 5-HT4 receptor ligands with opposing enantiomeric selectivityR M Eglen, D W Bonhaus, R D Clark, et al.
European Journal of Pharmacology|March 30, 1993
The effect of the 5-HT3 receptor antagonist, RS-42358-197, in animal models of anxietyB Costall, A M Domeney, M E Kelly, et al.
General Pharmacology|July 1, 1995
Chronic manipulation of dietary salt modulates renal physiology and kidney dopamine receptor subtypes: functional and autoradiographic studiesN A Sharif, J L Nunes, K D Lake, et al.
British Journal of Pharmacology|August 1, 1997
Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylaseW C Stanley, B Li, D W Bonhaus, et al.
Pageof 9